EUVIMEDEUVIMED entdecken
Crossref

Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline $^{18}$F-FDG-PET/CT Predict the Development of Distant Metastatic Disease?

Hinzpeter, Ricarda, Mirshahvalad, Seyed Ali, Kulanthaivelu, Roshini, Kohan, Andres, Ortega, Claudia, Metser, Ur und 14 weitere

Zurich Open Repository and Archive (University of Zurich) · 29.07.2024

DOI: 10.5167/uzh-261357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zurich Open Repository and Archive (University of Zurich), erschienen am 29.07.2024. Verfasst von Hinzpeter und 25 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to determine if clinical parameters and radiomics combined with sarcopenia status derived from baseline $^{18}$F-FDG-PET/CT could predict developing metastatic disease and overall survival (OS) in gastroesophageal cancer (GEC). Patients referred for primary staging who underwent $^{18}$F-FDG-PET/CT from 2008 to 2019 were evaluated retrospectively. Overall, 243 GEC patients (mean age = 64) were enrolled. Clinical, histopathology, and sarcopenia data were obtained, and primary tumor radiomics features were extracted. For classification (early-stage vs. advanced disease), the association of the studied parameters was evaluated. Various clinical and radiomics models were developed and assessed. Accuracy and area under the curve (AUC) were calculated. For OS prediction, univariable and multivariable Cox analyses were performed. The best model included PET/CT radiomics features, clinical data, and sarcopenia score (accuracy = 80%; AUC = 88%). For OS prediction, various clinical, CT, and PET features entered the multivariable analysis. Three clinical factors (advanced disease, age ≥ 70 and ECOG ≥ 2), along with one CT-derived and one PET-derived radiomics feature, retained their significance. Overall, $^{18}$F-FDG PET/CT radiomics seems to have a potential added value in identifying GEC patients with advanced disease and may enhance the performance of baseline clinical parameters. These features may also have a prognostic value for OS, improving the decision-making for GEC patients.

Schlagwörter

computed tomographygastroesophageal cancermetastasispositron emission tomographyradiomicssurvival

Zitieren

APA

Hinzpeter, Ricarda, Mirshahvalad, Ali, S., Kulanthaivelu, Roshini, Kohan, Andres, Ortega, Claudia, Metser, Ur, Liu, Amy, Farag, Adam, Elimova, Elena, Wong, …, & Patrick (2024). Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline $^{18}$F-FDG-PET/CT Predict the Development of Distant Metastatic Disease?. Zurich Open Repository and Archive (University of Zurich). https://doi.org/10.5167/uzh-261357

Vancouver

Hinzpeter, Ricarda, Mirshahvalad, Ali S, Kulanthaivelu, Roshini, et al. Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline $^{18}$F-FDG-PET/CT Predict the Development of Distant Metastatic Disease?. Zurich Open Repository and Archive (University of Zurich). 2024. doi:10.5167/uzh-261357

BibTeX
@article{Hinzpeter2024,
  author = {Hinzpeter and Ricarda and Mirshahvalad and Ali, Seyed and Kulanthaivelu and Roshini and Kohan and Andres and Ortega and Claudia and Metser and Ur and Liu and Amy and Farag and Adam and Elimova and Elena and Wong and S, Rebecca K and Yeung and Jonathan and Jang and Woo-Jun, Raymond and Veit-Haibach and Patrick},
  title = {Gastro-Esophageal Cancer: Can Radiomic Parameters from Baseline $^18$F-FDG-PET/CT Predict the Development of Distant Metastatic Disease?},
  journal = {Zurich Open Repository and Archive (University of Zurich)},
  year = {2024},
  doi = {10.5167/uzh-261357}
}
Kostenlos starten →